Lead Qualification Clause Samples

The Lead Qualification clause defines the criteria and process by which potential sales leads are evaluated to determine if they meet certain standards for further pursuit. Typically, this involves assessing factors such as the lead's budget, authority, need, and timeline, or other relevant attributes that indicate a genuine opportunity. By establishing clear benchmarks for what constitutes a qualified lead, this clause helps ensure that sales efforts are focused on prospects with the highest likelihood of conversion, thereby improving efficiency and reducing wasted resources.
Lead Qualification. The second stage of the Discovery Optimization Program will seek to qualify Active Compounds through [*****]. [*****]will be developed by screening selected Mapping Array Libraries that represent novel chemotypes identified in the Compass Array Library. [*****]. ----------------------- Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote such omissions.
View Source
Lead Qualification. The Parties expect to generate multiple Collaboration Compound Sets with activity for multiple Collaboration Targets (or, if the GTC Target is unknown, the anti-infective activity identified in the relevant assay) in the course of the Collaboration. The Parties further expect that the Research Committee will further qualify and prioritize the various opportunities presented by the combinations of Collaboration Compound Sets and Collaboration Targets (or, if the GTC Target is unknown, the anti-infective activity identified in the relevant assay) as described in the Collaboration Plan (e.g. evaluating their in vitro ADMET characteristics) and the Research Plan.
View Source
Lead Qualification. The Partner will identify Sellers who fulfill the below mentioned criteria: - (i) are interested in selling on the Marketplace; (ii) have a valid provisional or final goods and services tax registration number as applicable; and (iii) have received and provided a final goods and services tax registration number within the prescribed time limit, if provisional goods and services tax registration number was initially provided.
View Source
Lead Qualification. The second stage of the Discovery Optimization Program will seek to qualify Active Compounds through in vitro ADMET profiles and additional biological assays. Intial SAR will be developed by screening selected Mapping Array Libraries that represent novel chemotypes identified in the Compass Array
View Source
Lead Qualification. The Parties will seek to qualify Collaboration Compounds through additional biological assays, including functional assays, in vitro ADMET assays, bacterial inhibition assays, and other assays identified by the Research Committee. The biological assays for each project will be determined by the Research Committee and set forth in the Research Plan. The combination of initial SAR, in vitro activity evaluation, and in vitro ADMET profiling will enable the identification of qualified hits amenable to additional lead optimization efforts.
View Source
Lead Qualification 
View SourceView Similar (2)

Related to Lead Qualification

  • Required Qualifications At all times during the term of the Contract, Vendor shall have available, under direct employment and supervision and/or subcontract agreement fully incorporating the terms and conditions of the Contract Documents, the required qualified and properly licensed (as applicable) personnel to properly fulfill all the terms and conditions of the Contract.

  • Tax Qualification Each Employee Benefit Plan intended to be qualified under Section 401(a) of the Code has been determined to be so qualified by the Internal Revenue Service and nothing has occurred since the date of the last such determination which resulted or is likely to result in the revocation of such determination.

  • Formation and Qualification (a) Each Borrower is duly incorporated and in good standing under the laws of the state listed on Schedule 5.2(a) and is qualified to do business and is in good standing in the states listed on Schedule 5.2(a) which constitute all states in which qualification and good standing are necessary for such Borrower to conduct its business and own its property and where the failure to so qualify could reasonably be expected to have a Material Adverse Effect on such Borrower. Each Borrower has delivered to Agent true and complete copies of its certificate of incorporation and by-laws and will promptly notify Agent of any amendment or changes thereto. (b) The only Subsidiaries of each Borrower are listed on Schedule 5.2(b).

  • Regulation D Qualification Neither the Company nor, to its actual knowledge, any of its affiliates, members, officers, directors or beneficial shareholders of 20% or more of its outstanding securities, has experienced a disqualifying event as enumerated pursuant to Rule 506(d) of Regulation D under the Securities Act.

  • Organization and Qualification The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.